Q9992 – Injection, buprenorphine extended-release (sublocade), greater than 100 mg

Long description

Injection, buprenorphine extended-release (sublocade), greater than 100 mg

Short description

Buprenorphine xr over 100 mg

Pricing indicator

51 Drugs

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

O1E Other drugs

ASC

Approved for ambulatory surgical centers

Added

July 1, 2018

Last change

July 1, 2018 – No change

Nearby Q codes

• Q9983 – Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
• Q9984 – Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg
• Q9985 – Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
• Q9986 – Injection, hydroxyprogesterone caproate, (makena), 10 mg
• Q9987 – Pathogen(s) test for platelets
• Q9988 – Platelets, pheresis, pathogen-reduced, each unit
• Q9989 – Ustekinumab, for intravenous injection, 1 mg
• Q9991 – Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg
• Q9993 – Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
• Q9994 – In-line cartridge containing digestive enzyme(s) for enteral feeding, each
• Q9995 – Injection, emicizumab-kxwh, 0.5 mg
• Q9996 – Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg
• Q9997 – Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg
• Q9998 – Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg
• Q9999 – Injection, ustekinumab-aauz (otulfi), biosimilar, 1 mg